FIBrinogen REplenishment in Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

827

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

March 27, 2019

Conditions
Deficiency; Fibrinogen, Acquired
Interventions
DRUG

Octafibrin

Octafibrin will be administered when the blood bank receives an order for fibrinogen supplementation

DRUG

Cryoprecipitate

Cryoprecipitate will be administered when the blood bank receives an order for fibrinogen supplementation

Trial Locations (11)

V3L 3W7

Fraser University Royal Columbia, Vancouver

R2H 2A6

University of Manitoba, St Boniface General Hospital, Winnipeg

L8S 3Z5

Hamilton Health Science Centre, McMaster University, Hamilton

K7L 3N6

Kingston General Hsopital, Kingston

N6A 5A5

London Health Science Centre, London

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

M4N 3M5

Sunnybrook Health Science Centre, Toronto

M5B 1W8

St Michael's Hospital, Toronto

M5G 2C4

Tornoto General Hospital, University Health Network, Toronto

H1T 1C8

Montreal Heart Institute, Montreal

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie de Québec- Université Laval, Québec

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03037424 - FIBrinogen REplenishment in Surgery | Biotech Hunter | Biotech Hunter